Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

5.66
+0.03000.53%
Volume:217.71K
Turnover:1.23M
Market Cap:213.59M
PE:-5.44
High:5.80
Open:5.67
Low:5.60
Close:5.63
52wk High:7.19
52wk Low:1.00
Shares:37.74M
Float Shares:19.75M
Volume Ratio:1.01
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0401
EPS(LYR):-1.1641
ROE:-50.12%
ROA:-30.80%
PB:2.81
PE(LYR):-4.86

Loading ...

Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 11, 2023

Correspondence

CORRESP [Cover] - Correspondence
Mar 30, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 06, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report